Ohio Third Frontier (OTF), Ohio Development Services Agency
The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:
Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.
Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.
The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.
Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or firstname.lastname@example.org.
For more information on the TVSF visit the Ohio Third Frontier website.
Foundation Fighting Blindness and Harrington Discovery Institute
Foundation Fighting Blindness and Harrington Discovery Institute have partnered to form, the The National Center for Excellence in Fighting Blindness, a Gund-Harrington initiative. This initiative is focused on accelerating the translation of research findings in inherited retinal degenerative diseases (IRD) with the ultimate goal of developing new therapies to improve and/or restore vision.
• This Initiative seeks to award Gund-Harrington Scholar Awards that recognize innovators throughout the USA whose research has the potential to advance standards of care.
• There will be an average of three awards per year, which will be restricted to researchers working at institutions within the USA. Applications from outside the USA are not accepted.
• The Gund-Harrington Scholar Award provides funding for translational drug development and cell therapy along with non-financial project support to help bridge the gap between laboratory-based research and the clinic.
• Funding up to a total of $900,000 over three years and non-financial support will be provided by the The National Center for Excellence in Fighting Blindness. The non-financial support, provided by a team of pharmaceutical experts, will include project management and experienced industry advice in all aspects of drug development, encompassing chemistry, formulation, toxicology, regulatory, intellectual property and business development.
• Awards will be made to physician-scientists, or scientists with a research team that includes significant involvement of a physician with clinical expertise in the IRD.
• Selected projects must demonstrate a reasonable expectation that they can develop a lead product with strong potential for clinical and commercial application by the end of the three year funding period.
• Multi-disciplinary investigators outside the field of retinal disease are particularly encouraged to apply.
Applicants interested in the Gund-Harrington Scholar Awards must apply through Foundation Fighting Blindness.
For more information about Foundation Fighting Blindness visit the Fighting Blindness website.
Research Performance Progress Report Required for Non-SNAP Progress Reports Beginning October 17, 2014
The National Institutes of Health (NIH) currently requires use of the federal wide progress reporting format — known as the RPPR (Research Performance Progress Report) — to submit progress reports for Streamlined Non-competing Award Process (SNAP), fellowship, and multi-year funded awards. In April NIH opened the RPPR for use for all Type 5 Non-SNAP progress reports in anticipation of an October 2014 requirement for RPPR use.
Now, it’s official — all type 5 non-SNAP progress reports submitted on or after October 17, 2014 need to be submitted through the RPPR module of eRA Commons. This announcement is part of NIH’s ongoing transition to requiring the use of the federal government-wide RPPR format for all progress reporting.
NIH’s website on the RPPR provides information on the why, what, and when of the RPPR, with a handy table that lets you know for which types of grants the RPPR is now required, and for which it is still optional.
See more at: http://nexus.od.nih.gov/all/2014/06/30/rppr-required-for-non-snap-progress-reports-beginning-october-17-2014/?utm_source=nexus&utm_medium=email&utm_content=nihupdate&utm_campaign=jun13#sthash.8GUpbgGT.dpuf
Limited Submission Reminder: The Josiah Macy Jr. Foundation: Macy Faculty Scholars Program
Key Deadlines: December 29, 2014, 5:00pm (CWRU Letter of Intent), February 11, 2015, 5:00pm EST (agency application).
The Macy Faculty Scholars program is designed to identify and nurture the careers of promising educational innovators in medicine and nursing. With support from the Macy Foundation, scholars will implement new educational innovations at their home institutions and participate in career development activities.
Chosen scholars will receive:
• Salary support of up to $100,000 per year for two years
• At least 50% protected time for two years to pursue educational projects
• Active mentorship by a senior faculty member at their institution
• Access to the program’s national advisory committee
• Opportunities to participate in Macy conferences and other national meetings
An informational webinar for applicants will be held on December 8, 2014 at 2pm ET.
For more information on this limited submission opportunity, visit the Office of Research Administration website.
Take Advantage of All Pivot Has to Offer
For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.
CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.
Learn more about how to use all the features Pivot has to offer.
- provide access to the most comprehensive global source of funding opportunities;
- identify research expertise from within or outside of CWRU;
- foster collaboration by cultivating essential partnerships and alliances; and
- build strong network connections for future opportunities.
Sign up for a Pivot Webinar: https://refworks.webex.com/refworks/onstage/g.php?p=4&t=m.
Learn to use Pivot via YouTube: http://www.youtube.com/proquestpivot.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
email@example.com no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be